X-120075904-A-C
Position:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_001099685.3(RHOXF2B):āc.533T>Gā(p.Val178Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.00054 ( 0 hom., 0 hem., cov: 8)
Exomes š: 0.00030 ( 0 hom. 0 hem. )
Failed GnomAD Quality Control
Consequence
RHOXF2B
NM_001099685.3 missense
NM_001099685.3 missense
Scores
8
4
5
Clinical Significance
Conservation
PhyloP100: 0.745
Genes affected
RHOXF2B (HGNC:33519): (Rhox homeobox family member 2B) Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II transcription regulatory region sequence-specific DNA binding activity. Involved in positive regulation of gene expression. Predicted to be located in nucleus. Predicted to be part of chromatin. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.09601763).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RHOXF2B | NM_001099685.3 | c.533T>G | p.Val178Gly | missense_variant | 3/4 | ENST00000371402.5 | NP_001093155.1 | |
RHOXF1-AS1 | NR_131238.1 | n.297+39372A>C | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RHOXF2B | ENST00000371402.5 | c.533T>G | p.Val178Gly | missense_variant | 3/4 | 1 | NM_001099685.3 | ENSP00000360455 | P1 | |
RHOXF1-AS1 | ENST00000553843.5 | n.297+39372A>C | intron_variant, non_coding_transcript_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.00 AC: 32AN: 58998Hom.: 0 Cov.: 8 AF XY: 0.00 AC XY: 0AN XY: 6368 FAILED QC
GnomAD3 genomes
AF:
AC:
32
AN:
58998
Hom.:
Cov.:
8
AF XY:
AC XY:
0
AN XY:
6368
FAILED QC
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000251 AC: 15AN: 59646Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 9100
GnomAD3 exomes
AF:
AC:
15
AN:
59646
Hom.:
AF XY:
AC XY:
0
AN XY:
9100
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.000305 AC: 120AN: 393951Hom.: 0 Cov.: 5 AF XY: 0.00 AC XY: 0AN XY: 120965
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
120
AN:
393951
Hom.:
Cov.:
5
AF XY:
AC XY:
0
AN XY:
120965
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Data not reliable, filtered out with message: AS_VQSR AF: 0.000542 AC: 32AN: 58998Hom.: 0 Cov.: 8 AF XY: 0.00 AC XY: 0AN XY: 6368
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
32
AN:
58998
Hom.:
Cov.:
8
AF XY:
AC XY:
0
AN XY:
6368
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ExAC
AF:
AC:
5
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 23, 2021 | The c.533T>G (p.V178G) alteration is located in exon 3 (coding exon 3) of the RHOXF2B gene. This alteration results from a T to G substitution at nucleotide position 533, causing the valine (V) at amino acid position 178 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Benign
DANN
Uncertain
DEOGEN2
Pathogenic
D
FATHMM_MKL
Benign
N
LIST_S2
Benign
T
M_CAP
Benign
T
MetaRNN
Benign
T
MetaSVM
Uncertain
D
MutationAssessor
Pathogenic
H
MutationTaster
Benign
N
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D
REVEL
Uncertain
Sift
Pathogenic
D
Sift4G
Pathogenic
D
Polyphen
D
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at